Chapter title |
Phototherapy in Atopic Dermatitis
|
---|---|
Chapter number | 23 |
Book title |
Ultraviolet Light in Human Health, Diseases and Environment
|
Published in |
Advances in experimental medicine and biology, January 2017
|
DOI | 10.1007/978-3-319-56017-5_23 |
Pubmed ID | |
Book ISBNs |
978-3-31-956016-8, 978-3-31-956017-5
|
Authors |
José María Ortiz-Salvador, Amparo Pérez-Ferriols, Ortiz-Salvador, José María, Pérez-Ferriols, Amparo |
Abstract |
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. Currently management of AD includes avoidance of triggering factors, skin care aiming to compensate the skin barrier defects, anti-inflammatory therapy (mostly topical corticosteroids and topical calcineurin inhibitors). When these first-line approaches are unsuccessful, systemic treatment or phototherapy ought to be carried out as next line of defence. Current phototherapy modalities for AD include broadband UVB (290-320 nm), narrowband UVB (311-313 nm), UVA-1 therapy (340-400 nm), UVA therapy plus 8-methoxypsoralens (PUVA), 308 nm excimer laser (EL) and Full spectrum light (FSL). |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 22% |
Student > Bachelor | 7 | 19% |
Student > Postgraduate | 4 | 11% |
Other | 3 | 8% |
Researcher | 2 | 6% |
Other | 4 | 11% |
Unknown | 8 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 36% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 11% |
Chemistry | 2 | 6% |
Psychology | 1 | 3% |
Veterinary Science and Veterinary Medicine | 1 | 3% |
Other | 2 | 6% |
Unknown | 13 | 36% |